Cannabis Law Report

JANUARY 15, 2019

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

Epilepsy 71

Epilepsy Cannabinoids Treatment Research and Development 71

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. –(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Understanding how to discern reliable sources, interpret research methodologies, and apply key findings to real-world scenarios can be daunting.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 105

Medicine Research and Development Agriculture Compliance 105

Medicinal Marijuana Association

FEBRUARY 11, 2024

Have you ever wondered how cannabinoids interact with your body’s systems? From influencing mood and memory to regulating pain and appetite, cannabinoids play a crucial role in maintaining balance within the body. Key Takeaways Cannabinoids like THC and CBD impact the body through various receptors and maintain balance.

Cannabinoids 52

Cannabinoids Chronic Pain Blood Pressure Research and Development 52

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Otherside Farms

MAY 6, 2019

ASD usually develops during childhood and is a neurodevelopmental condition which often involves compulsive and repetitive behavior. We still don’t know what causes the development of ASD, with scientists believing that it is probably a mixture of genetic and environmental factors. ASD and Epilepsy. CBD and Epilepsy.

Epilepsy 77

Epilepsy CBD Research and Development Therapy 77

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

MMJ Recs

FEBRUARY 3, 2021

Cannabinoids are a group of chemical substances that exist both within the human body and in nature. Cannabinoids make up the endocannabinoid system in the body, a system that plays a role in communication between the brain and the body. In medical marijuana, cannabinoids are found in the cannabis sativa plant.

Cannabinoids 52

Cannabinoids Patients Blood Pressure Chronic Pain 52

MMJ Recs

FEBRUARY 18, 2024

As society re-evaluates its stance on cannabis, a growing body of research is uncovering the therapeutic potential of this plant. The active compounds in marijuana, known as cannabinoids, interact with the body’s endocannabinoid system to produce therapeutic effects.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

Cannabis Law Report

JANUARY 10, 2022

Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Medicinal Marijuana Association

AUGUST 27, 2019

Extensive research in the United States and England on cannabis in the 1930s came to a halt with the beginning of World War II and did not pick up again afterwards due to the various laws and regulations that classified the plant as a drug.Legal issuescontinued to inhibit serious study until half a century ago, when Prof.

Research and Development 66

Research and Development Clinical Trials Patients Epilepsy 66

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

LifeCannMD

FEBRUARY 27, 2024

The Science Behind Medical Marijuana and Its Effects on Epileptic Seizures Medical Marijuana has garnered significant attention for its benefits in treating epilepsy and seizures. Inflammation in the brain is thought to contribute to the development and persistence of seizures.

Clinical Trials 59

Clinical Trials Epilepsy Marijuana Research and Development 59

PrestoDoctor

SEPTEMBER 26, 2023

Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. It’s important to note that not everyone who uses cannabis will develop mental health issues. Research suggests that there is indeed a link between cannabis use and mental health issues.

Research and Development 105

Research and Development Chronic Pain Sleep Conditions 105

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. Let’s go over the three main components of ECS to better understand, they are: endocannabinoids, cannabinoid receptors, and enzymes.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

MMJ Recs

JULY 5, 2024

It is one of over 100 cannabinoids present in cannabis, and it is responsible for the “high” or euphoric sensation typically associated with cannabis use. THC interacts with cannabinoid receptors in the brain and nervous system, which are part of the endocannabinoid system (ECS). Image by Richard T on Unsplash.

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

United Patients Group

FEBRUARY 8, 2023

Natural opioids include opium or poppy seeds; synthetic ones were first developed in 1950s by German chemist Paul Janssen, who went on to found Janssen Pharmaceutica NV (now part of Johnson & Johnson). Cannabinoids may have potential in treating chronic pain. Cannabinoids may have potential in treating chronic pain.

Chronic Pain 105

Chronic Pain Cannabinoids Research and Development Patients 105

Cannabis Law Report

AUGUST 10, 2021

The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with refractory epilepsy.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

United Patients Group

OCTOBER 25, 2023

Medical marijuana’s therapeutic effects are primarily due to its active compounds, known as cannabinoids. The two primary cannabinoids are delta-9-tetrahydrocannabinol ( THC ) and cannabidiol ( CBD ). Can You Become Addicted to Medical Marijuana?

Marijuana 105

Marijuana Patients Research and Development Edibles 105

United Patients Group

JULY 7, 2023

While there is still much research to be done on the potential benefits and risks of medical cannabis, there is a growing body of evidence that suggests it can be a valuable tool for managing chronic pain, anxiety and depression, nausea and vomiting, seizures, inflammation, sleep, and other health conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

United Patients Group

JULY 29, 2024

Research has also shown that cannabis contains terpenes , aromatic compounds that contribute to its therapeutic effects. The entourage effect, where these compounds work synergistically with cannabinoids, further enhances the plant’s medicinal potential.

Research and Development 52

Research and Development Strains Chronic Pain Medicine 52

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. The company has begun preparation that will facilitate the commencement of the clinical study and engaged with a contract research organization (CRO) to provide support for the trial.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

The Herb Collective

AUGUST 1, 2023

The cannabinoids found in Cannabis Indica have been shown to have a relaxing effect on the body, which causes a decrease in blood pressure. While the exact mechanisms behind this phenomenon are still being researched, the results are promising.

Indica 87

Indica Blood Pressure Epilepsy Sleep 87

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. The two cannabinoids can also cause very different effects in other ways.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. In a 47 acre greenhouse – close to the size of 42 football fields – GW is developing and delivering strains of medicinal cannabis.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. The World Health Organization (WHO) reports approximately 2.5%

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Veriheal

JANUARY 18, 2023

In 2018, legislation was passed by the British Parliament that effectively legalized cannabinoids like CBD and CBDA. Research commissioned by the Centre for Medicinal Cannabis pinned a £1 billion valuation on the CBD market by the year 2025. Confusion surrounding British CBD laws has thrust the cannabinoid into a legal gray area.

CBD 97

CBD Strains Research and Development Oil 97

Veriheal

DECEMBER 8, 2023

The report is expected to touch on the following: The medical potential of cannabis and CBD for serious conditions like epilepsy The effects of delta-9 THC on brain development, and driving abilities Barriers to cannabis research in states where cannabis is illegal Recommendations on regulations and testing needed for more accurate cannabinoid level (..)

Recreational 104

Recreational Research and Development Epilepsy THC 104

Cannabis Law Report

DECEMBER 23, 2021

Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. C3 Cannabinoid Compound Company. Companies Mentioned.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

TheAnswerPage

JULY 22, 2021

Some cannabinoid-based drugs have been approved by national drug administrations. Other than seizure disorders, what are the therapeutic indications for cannabinoid-based medicines that have been approved by a national drug administration? Research, Society and Development, [S. de; SILVA , A. ABREU , L. GONZAGA, R.

Research and Development 52

Research and Development Epilepsy Treatment Cannabinoids 52

Cannabis Law Report

JANUARY 16, 2022

Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland. Some conditions for which cannabis-based treatment has been advocated include epilepsy, neuropathic pain and chronic widespread pain as well as appetite problems, nausea and vomiting and pain in cancer patients.

Pharmaceutical 98

Pharmaceutical Research and Development Epilepsy Medicine 98

United Patients Group

FEBRUARY 2, 2023

It’s made up of endocannabinoids and cannabinoid receptors, which work together to maintain homeostasis in the body by regulating things like mood, energy, appetite and sleep cycles. The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). antibiotics).

Blood Pressure 105

Blood Pressure Sleep Chronic Pain Digestion 105

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. after injection.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system. In 1970, the U.S.

CBD 100

CBD DEA Research and Development Hemp 100

Medicinal Marijuana Association

FEBRUARY 11, 2024

Endocannabinoid System Overview Understanding the endocannabinoid system is crucial for grasping how cannabinoids interact with your body to regulate various physiological functions and maintain balance. Cannabinoids such as CBD work by binding to specific receptors and influencing various physiological processes.

CBD 52

CBD Research and Development Topical Cannabinoids 52